Detalhe da pesquisa
1.
Exploring the Combined Action of Adding Pertuzumab to Branded Trastuzumab versus Trastuzumab Biosimilars for Treating HER2+ Breast Cancer.
Int J Mol Sci
; 25(7)2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38612751
2.
Phase III study to evaluate patient's preference of subcutaneous versus intravenous trastuzumab in HER2-positive metastatic breast cancer patients: Results from the ChangHER study (GEICAM/2012-07).
Eur J Cancer Care (Engl)
; 29(4): e13253, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32578279
3.
Optimal [18F]FDG PET/CT Cutoff for Pathologic Complete Response in HER2-Positive Early Breast Cancer Patients Treated with Neoadjuvant Trastuzumab and Pertuzumab in the PHERGain Trial.
J Nucl Med
; 65(5): 708-713, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38575192
4.
Analysis of tumor infiltrating CD4+ and CD8+ CDR3 sequences reveals shared features putatively associated to the anti-tumor immune response.
Front Immunol
; 14: 1227766, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37600765
5.
Open-label phase II clinical trial of ketoconazole as CYP17 inhibitor in metastatic or advanced non-resectable granulosa cell ovarian tumors: the GREKO (GRanulosa Et KetOconazole) trial, GETHI 2011-03.
Clin Transl Oncol
; 25(7): 2090-2098, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36708371
6.
Trastuzumab deruxtecan in patients with central nervous system involvement from HER2-positive breast cancer: The DEBBRAH trial.
Neuro Oncol
; 25(1): 157-166, 2023 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35639825
7.
Vitamin D threshold to prevent aromatase inhibitor-related bone loss: the B-ABLE prospective cohort study.
Breast Cancer Res Treat
; 133(3): 1159-67, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22434523
8.
[Two cases of pituitary metastases as initial presentation form of small cell lung cancer]. / Dos casos de metástasis hipofisarias como forma de presentación de un carcinoma microcítico de pulmón.
Invest Clin
; 53(4): 402-7, 2012 Dec.
Artigo
em Espanhol
| MEDLINE | ID: mdl-23513490
9.
Evaluation of the TCR Repertoire as a Predictive and Prognostic Biomarker in Cancer: Diversity or Clonality?
Cancers (Basel)
; 14(7)2022 Mar 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35406543
10.
Trastuzumab deruxtecan in HER2-positive metastatic breast cancer and beyond.
Expert Opin Biol Ther
; 21(7): 811-824, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33759669
11.
COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry.
Ther Adv Med Oncol
; 13: 17588359211053416, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34777582
12.
Neratinib plus capecitabine for the treatment of advanced HER2-positive breast cancer.
Expert Rev Anticancer Ther
; 20(9): 731-741, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32862744
13.
AI-related BMD variation in actual practice conditions: A prospective cohort study.
Endocr Relat Cancer
; 23(4): 303-12, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26911377
14.
[Metastatic intestinal perforation secondary to a primary lung tumour]. / Perforación intestinal secundaria a metástasis de neoplasia primaria de pulmón.
Cir Esp
; 87(4): 257-9, 2010 Apr.
Artigo
em Espanhol
| MEDLINE | ID: mdl-19577740
15.
Skeletal adverse effects with aromatase inhibitors in early breast cancer: evidence to date and clinical guidance.
Ther Adv Med Oncol
; 7(5): 291-6, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26327926
16.
Bone health in a prospective cohort of postmenopausal women receiving aromatase inhibitors for early breast cancer.
Breast
; 21(1): 95-101, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21924904
17.
Dos casos de metástasis hipofisarias como forma de presentación de un carcinoma microcítico de pulmón / Two cases of pituitary metastases as initial presentation form of small cell lung cancer
Invest. clín
; 53(4): 402-407, dic. 2012. ilus, tab
Artigo
em Espanhol
| LILACS | ID: lil-687432